The 3.7-fold higher uptake of [68Ga]Ga-NODAGA-S1 in MSLNhigh A1847 than in MSLNlow MDA-MB-231 tumours associated with the competing effect of non-labelled S1 and a low off-target uptake confirmed the specific targeting of MSLN by Nb S1. Here, MSLN is linked to neoplasm.